Martingale Asset Management L P Horizon Therapeutics Public LTD CO Transaction History

Martingale Asset Management L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $928,115 - $1.23 Million	-12,921 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $764,269 - $962,636	-11,407 Reduced 46.89%	12,921 $945,000
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $170,771 - $247,143	-3,092 Reduced 11.28%	24,328 $1.89 Million
Q2 2020 Aug 10, 2020	SELL	$30.2 - $56.98 $267,904 - $505,469	-8,871 Reduced 24.44%	27,420 $1.52 Million
Q1 2020 May 11, 2020	BUY	$24.87 - $38.56 $367,180 - $569,299	14,764 Added 68.58%	36,291 $1.07 Million

Q4 2019 Feb 10, 2020	BUY	$25.43 - $36.67 $275,000 - $396,549	10,814 Added 100.94%	21,527 $779,000
Q3 2019 Nov 13, 2019	BUY	$23.0 - $27.97 $246,399 - $299,642	10,713 New	10,713 $291,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.